Modulating the immune response, which helps alleviate symptoms of autoimmune diseases and MCAS
Men over 50, smokers and obese individuals face higher risk and need regular screenings
Yang B, Lin X, Yu N, Gao H, Zhang Y, Liu W
Clinical trials leading to FDA approval demonstrated significant visceral fat reduction in patients with excess abdominal fat accumulation, validating what clinicians now see consistently in practice
Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair [1] [2]